Renovaro (RENB) News Today → We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad) Free RENB Stock Alerts $1.29 -0.04 (-3.01%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 24, 2024 | globenewswire.comRenovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer ImmunotherapyMay 24, 2024 | tmcnet.comBiotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032May 16, 2024 | finance.yahoo.comRenovaro Inc. (RENB)May 16, 2024 | investorplace.comRENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024May 15, 2024 | washingtonpost.comRenovaro: Fiscal Q3 Earnings SnapshotApril 30, 2024 | globenewswire.comTransforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on FragmentomicsApril 24, 2024 | globenewswire.comRenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics PartnershipApril 20, 2024 | uk.investing.comRenovaro appoints distinguished professor as new Chair of Scientific BoardApril 18, 2024 | finance.yahoo.comRenovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient CareMarch 15, 2024 | marketbeat.comRenovaro Inc. (NASDAQ:RENB) Sees Large Decline in Short InterestRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the target of a large decline in short interest in February. As of February 29th, there was short interest totalling 825,900 shares, a decline of 24.9% from the February 14th total of 1,100,000 shares. Based on an average daily volume of 195,900 shares, the short-interest ratio is currently 4.2 days. Currently, 1.5% of the company's stock are short sold.March 12, 2024 | markets.businessinsider.comONGOING INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBMarch 10, 2024 | markets.businessinsider.comINVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RenovaroMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 28, 2024 | stockhouse.comRenovaro Shareholder NoticeFebruary 26, 2024 | stockhouse.comRenovaro Shareholder AlertFebruary 25, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 23, 2024 | finance.yahoo.comRENB Apr 2024 2.500 callFebruary 22, 2024 | investorplace.comRed Flag Alert: 3 Stocks That Hindenburg Research Is Shorting NowFebruary 18, 2024 | markets.businessinsider.comRenovaro Ongoing Investor AlertFebruary 17, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 16, 2024 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 15, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENBFebruary 15, 2024 | globenewswire.comCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplaceFebruary 14, 2024 | sg.finance.yahoo.comHit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion PieceFebruary 14, 2024 | msn.comRenovaro Biosciences soars after responding to Hindenburg short callFebruary 14, 2024 | finanznachrichten.deRenovaro Biosciences Inc.: Statement of Renovaro IncFebruary 14, 2024 | finance.yahoo.comStatement of Renovaro IncFebruary 14, 2024 | globenewswire.comStatement of Renovaro IncFebruary 14, 2024 | stockhouse.comRenovaro Investor AlertFebruary 13, 2024 | tmcnet.comROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENBFebruary 13, 2024 | finance.yahoo.comCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplaceFebruary 13, 2024 | businesswire.comROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENBFebruary 13, 2024 | marketbeat.comTrading was temporarily halted for "RENB" at 09:02 AM with a stated reason of "LULD pause."February 13, 2024 | marketbeat.comTrading was temporarily halted for "RENB" at 09:02 AM with a stated reason of "LULD pause."February 8, 2024 | msn.comRenovaro Biosciences Expands Share Capital SignificantlyJanuary 26, 2024 | msn.comRenovaro Biosciences Announces Final Meeting Vote ResultsJanuary 25, 2024 | finanznachrichten.deRenovaro Biosciences Inc.: Renovaro Biosciences Announces Results of Special Meeting of ShareholdersJanuary 25, 2024 | finance.yahoo.comRenovaro Biosciences Announces Results of Special Meeting of ShareholdersJanuary 18, 2024 | finance.yahoo.comRenovaro BioSciences Releases CEO Shareholder MessageJanuary 17, 2024 | theglobeandmail.comRenovaro BioSciences (NASDAQ: RENB) Releases CEO Shareholder MessageJanuary 16, 2024 | tmcnet.comMessage from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MDJanuary 16, 2024 | finance.yahoo.comMessage from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MDJanuary 11, 2024 | stockhouse.comSHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates RENB, HA, AYXDecember 1, 2023 | finance.yahoo.comRenovaro BioSciences CEO Featured in Recent Proactive InterviewNovember 23, 2023 | finance.yahoo.comRenovaro BioSciences Poised to Spearhead Advancements in Battle Against DiseasesNovember 22, 2023 | finance.yahoo.comRenovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024November 21, 2023 | finance.yahoo.comRenovaro BioSciences Eyes Opportunity in Precision Medicine MarketNovember 16, 2023 | marketbeat.comUnlocking AI investment opportunities in healthcare (RENB)AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address After Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown. Click here to see the details because this coming election meltdown could trigger… RENB Media Mentions By Week RENB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼0.000.73▲Average Medical News Sentiment RENB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼01▲RENB Articles Average Week Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aurinia Pharmaceuticals News Zentalis Pharmaceuticals News Tango Therapeutics News Olema Pharmaceuticals News Evolus News Wave Life Sciences News Phibro Animal Health News Praxis Precision Medicines News Nuvation Bio News Longboard Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored